Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is extraskeletal myxoid chondrosarcoma?
Despite its name, extraskeletal myxoid chondrosarcoma is not really a cartilage cancer and does not arise in bone. It is a distinct soft-tissue sarcoma, usually found as a deep lump in the thigh or other large muscles of the limbs in middle-aged adults. 'Myxoid' refers to the jelly-like material that fills the tumor. It is defined by a characteristic gene rearrangement — most often NR4A3 (also called CHN/TEC) fused to a partner gene such as EWSR1 — which pathologists use to confirm the diagnosis, since it can be mistaken for other myxoid tumors. Its behavior is unusual: it usually grows slowly and patients often live a long time, yet it has a high tendency to come back locally and to spread to the lungs, sometimes a decade or more after the original tumor was treated. That makes complete removal and very long-term follow-up essential.
The main types
Doctors group extraskeletal myxoid chondrosarcoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Classic (low-grade) extraskeletal myxoid chondrosarcoma | The usual form, rich in jelly-like myxoid material, growing slowly over years. |
| High-grade / cellular variant | A more cellular, faster-growing version with a higher chance of spreading; treated more aggressively. |
| Defined by NR4A3 gene fusion | Not a separate tumor but the molecular hallmark — testing for the NR4A3 rearrangement confirms the diagnosis and separates it from look-alike tumors. |
Staging, in plain terms
Soft-tissue sarcomas are staged by tumor size and depth (T), lymph-node involvement (N, uncommon here), distant spread (M), and grade — how aggressive the cells look. For this slow-growing tumor, grade and whether it has reached the lungs matter most for outlook.
| Soft-tissue sarcoma TNM + grade | What it generally means |
|---|---|
| Localized, low-grade | A tumor confined to its original site with a gentle microscopic appearance. Usually controlled by complete surgery, though long follow-up is still needed. |
| Localized, higher-grade or large | Bigger or more cellular tumors still confined locally, where radiation is added to surgery to reduce recurrence. |
| Metastatic (most often lung) | Spread, when it happens, typically goes to the lungs and may appear years later. Often slow-growing even when metastatic, allowing targeted local treatment of individual spots. |
The standard of care
Extraskeletal Myxoid Chondrosarcoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery (the cornerstone)
Wide removal of the tumor with a rim of healthy tissue offers the best chance of long-term control. Limb-sparing surgery is the goal whenever possible.
Radiation therapy
Given before or after surgery for larger, higher-grade, or close-margin tumors to lower the high risk of local recurrence — radiation plays a central role in this recurrence-prone sarcoma.
Treating lung spread directly
Because metastases are often few and slow, individual lung deposits can be removed surgically or treated with focused stereotactic radiation (SBRT) rather than only with drugs.
Systemic therapy and trials
Standard chemotherapy has limited effect; antiangiogenic drugs (such as sunitinib or pazopanib) and clinical trials are used for widespread or progressing disease.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they lose the ability to divide, while normal tissue repairs itself and recovers. In extraskeletal myxoid chondrosarcoma, radiation is used around surgery to reduce the strong tendency for the tumor to return locally, and as precise SBRT to destroy individual lung metastases. Treatment is delivered as a series of short, painless daily sessions (or a few sessions for SBRT) and leaves no radioactivity in your body, so you remain safe to be around others throughout.
The main ways radiation is delivered for extraskeletal myxoid chondrosarcoma:
Intensity-modulated / image-guided radiation (IMRT/IGRT)
Sculpted, image-guided x-ray beams deliver a high dose to the tumor or surgical bed while sparing nearby skin, bone, and joints to preserve limb function.
Stereotactic body radiation therapy (SBRT)
Very precise, high-dose beams from many angles can ablate individual lung metastases in a few sessions, a good fit for this tumor's slow, oligometastatic spread.
Proton therapy (selected cases)
Protons can reduce dose to surrounding tissue for tumors near the spine, pelvis, or other sensitive structures.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Long survival despite frequent late relapse: Large series confirm that patients often survive many years even with metastatic disease, but local recurrence and late lung spread are common — underscoring aggressive local treatment and decades-long surveillance.[1]
Connective Tissue Oncology Society / sarcoma center series
NR4A3 fusion confirms the diagnosis: Molecular testing for the NR4A3 (CHN/TEC) rearrangement reliably distinguishes this tumor from other myxoid sarcomas, improving accurate diagnosis and treatment planning.[2]
Sarcoma molecular pathology reviews
Antiangiogenic drugs for advanced disease: Tyrosine-kinase inhibitors such as sunitinib and pazopanib have produced responses or durable disease control in metastatic cases that resist standard chemotherapy.[3]
Prospective and retrospective sarcoma trials
Common questions
Is this a bone or cartilage cancer? No — despite the word 'chondrosarcoma' in its name, it is a soft-tissue sarcoma that arises in muscle and other soft tissues, not in bone or true cartilage. The name reflects its appearance under the microscope, not its origin or behavior.
Why do I need follow-up for so many years? This tumor is famous for coming back or spreading to the lungs very late — sometimes 10 years or more after treatment. Long-term scans let your team catch and treat any recurrence early, often with surgery or precise radiation.
If it spreads to my lungs, is treatment hopeless? Not at all. Because spread is often slow and limited to a few spots, individual lung tumors can be removed or ablated with focused radiation, and many patients live well for years even with metastatic disease.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.